Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to Overweight from Equal Weight with a price target of $75, which was up from ...

Abstract: Continuous health monitoring by placing sensors onto and into the human body has emerged as a pivotal approach in healthcare. This paper delves into the vast array of opportunities presented ...

GlucoModicum today unveiled Sofio, which it labels the world's first needle-free glucose monitor based on ...